Found 487 clinical trials
CoV-ICU Score Intensive Care Unit SARS-CoV-2
In the course of COVID disease, some patients need intensive care treatment. We aim to find an answer to the question of whether the patient's CRP, ferritin, D-dimer, Oxygen Saturation, lymphocyte count, and body mass index can be used as a criterion for admitting patients with COVID to the intensive …
- 0 views
- 19 Feb, 2024
- 1 location
Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19
There is still no effective antiviral drugs and vaccines against SARS-CoV-2 yet now. This is an obsevational study, the investigators collected the clinical information and clinical outcomes of the COVID-19 patients using anti-2019-nCoV inactivated convalescent plasma.The study is to evaluate the efficacy and safety of anti-2019-nCoV inactivated convalescent plasma in …
- 0 views
- 19 Feb, 2024
- 1 location
Hospital Registry of Acute Myocarditis: Evolution of the Proportion of Positive SARS-COV-2 (COVID19) Cases
To date, the effects of SARS-Cov-2 (Covid-19) on the myocardium and the role it plays in the evolution towards an acute myocarditis are badly understood. The current pandemic of this emerging virus is an opportunity to assess the proportion of acute myocarditis attributable to SARS-Cov-2(Covid-19) and to assess the clinical, …
- 0 views
- 19 Feb, 2024
- 1 location
Systematic Assessment of SARS-CoV-2 Neurotropic Capacity in Modestly and Critically Ill Patients and Patients Who Died From COVID-19
The peripheral (cerebrospinal fluid and peripheral blood) cytokine response to SARS-CoV-2 is investigated in regard to CNS affection and consecutive blood brain barrier disruption leading to braininherent neuroinflammatory reactions
- 0 views
- 19 Feb, 2024
- 2 locations
Prognostic Factors of COVID19
The secondary objectives are Monitoring of viral replication of SARS-CoV-2 in the blood and respiratory tract in infected patients Monitoring of the humoral and cellular response directed against SARS-CoV-2 Identification of factors leading to significant and / or prolonged viral replication of SARS-CoV-2 in the blood or respiratory samples Evaluation …
- 0 views
- 19 Feb, 2024
- 1 location
Analysis of the Inflammatory Response and the Development of Humoral and Cellular Immunity in Patients With COVID-19
The SARS-CoV-2 infection in the airway epithelium induces cytopathic effects and the cessation of ciliary movement. Increased cytokines and chemokines have been reported to be associated with the severity of the disease.
- 0 views
- 19 Feb, 2024
- 1 location
IgG/IgM Antibody Test in Patients Who Have Tested Negative or Positive for COVID-19 With the Standard Method of COVID19 Testing.
The purpose of this study is to evaluate point of care SARS-Cov2 Virus IgG/IgM rapid test cassette Clungene test and correlate it with the standard method of testing in inpatients who have tested positive or negative for COVID19.
- 0 views
- 19 Feb, 2024
- 3 locations
Collection of Coronavirus COVID-19 Outbreak Samples in New South Wales
Participants can be enrolled at any timepoint (up to 6 months) following diagnosis of SARS-CoV-2 infection (COVID-19). Blood samples and clinical data will be collected.
- 0 views
- 19 Feb, 2024
- 9 locations
Genetic Basis of COVID-19 Infection
We will study genetic factors causing severe disease due to infection with SARS-COV-2 which may help to find targeted therapy
- 0 views
- 19 Feb, 2024
- 1 location
Bicentric Study on the Use of ECMO-VV or VA for Severe ARDS Associated With Covid-19
Describes the cohort of patients receiving ECMO-VV or ECMO-VA in the management of severe ARDS refractory to SARS-CoV-2 in the Strasbourg and Louvain centres
- 0 views
- 19 Feb, 2024
- 1 location